Find your next paid study

Zumutor Biologics Inc.NCT06451497

Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more

SHARON: Study of Metastatic Cancers in Patients Using Autologous Stems Cells and Potentiated Redox Cycling to Overcome Drug Resistance to Nitrogen Mustard Derivatives

The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic…

Prostate CancerProstate Cancer Metastatic

General Oncology, Inc.

Prostate Cancer Geriatric Assessment and Technology Evaluation (ProsGATE) Study

By doing this study, doctors hope to learn more about factors that contribute to frailty (a condition where older adults feel weak, get tired easily, and strug…

University of ChicagoNCT06215508

~$10 – $750

Observational

Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)

This study is about adding PSMA PET (Prostate Specific Membrane Antigen- Positron Emission Tomography) to routine magnetic resonance imaging (MRI) scans to hel…

Prostate Cancer (Adenocarcinoma)Prostate Cancer (Diagnosis)Prostate Cancer Metastatic Disease

University of ChicagoNCT07115914

~$10 – $6,250

Phase 2

A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma

The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-10…

Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV

Panbela Therapeutics, Inc.NCT05254171

Phase 2

A Phase II Trial of Hepatic Ablation of Metastases to Modulate and Enhance Immunotherapy Response (HAMMER) in NSCLC

The purpose of this study is to see whether adding liver stereotactic ablative radiotherapy/L-SABR to standard drug therapy is better than standard drug therap…

Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon-small Cell Carcinoma+2 more

Memorial Sloan Kettering Cancer CenterNCT05657873

~$10 – $6,250

Phase 2

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity, PSA Decline and Genetic Variation in Proteins Involved in Androgen Metabolism in Metastatic Hormone Naive Prostate Cancer

The investigators are conducting this study with men that have prostate cancer and are getting standard of care treatment with the drugs abiraterone acetate an…

Prostate Cancer MetastaticProstate Cancer

~$10 – $7,500

Martha MimsNCT03833921

Lung Cancer, Non-small CellLung Cancer MetastaticSolid Tumor, Adult+2 more

KB707-02: A Phase 1/2 Study of Inhaled KB707 in Patients With Advanced Solid Tumor Malignancies Affecting the Lungs

The Sponsor is developing KB707, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector designed to stimulate an anti-tumo…

Krystal Biotech, Inc.NCT06228326

Genetics of Appendix Cancer: The GAP Study

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individu…

Appendix CancerAppendiceal CancerAppendiceal Neoplasms+12 more

Andreana Holowatyj, PhD, MSCINCT05734430

~$10 – $1,125

Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more

A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer

Incyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule inhibitor of cyclin dependent kinase 2 (CDK2) for the treatment of human cancers. This…

Incyclix BioNCT05735080

Lung CancerLung Cancer MetastaticBrain Metastases+1 more

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography for Staging, Response Assessment, and Patient Selection in Metastatic Non-Small Cell Lung Cancer

This study investigates fluorine-18-AlphaVBeta6-BP (\[18F\]-αvβ6-BP) as a Positron Emission (PET) imaging agent in Non-Small Cell Lung Cancer (NSCLC) patients …

University of California, DavisNCT05452005

~$10 – $6,250

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test (eAArly DETECT)

The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or adva…

Colorectal Cancer ScreeningColorectal Cancer MetastaticColon Adenocarcinoma